Android app Apple app link

Verona Pharma plc (VRNA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$106.79

south_east
-$0.03 (-0.03%)
Day's range
$106.79
Day's range
$106.85

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/14/2025 H.C. Wainwright Raghuram Selvaraju $107.00 $104.67   2.23%
01/10/2025 Roth Capital Boobalan Pachaiyappan $68.00 $45.20   50.44%
01/08/2025 Wells Fargo Tiago Fauth $74.00 $49.55   49.34%
11/05/2024 H.C. Wainwright Raghuram Selvaraju $42.00 $38.39   9.4%
07/22/2024 Canaccord Genuity Edward Nash $37.00 $22.95   61.22%
06/27/2024 H.C. Wainwright Raghuram Selvaraju $36.00 $14.69   145.06%
05/28/2024 Jefferies Andrew Tsai $38.00 $12.50   204%
04/16/2024 Piper Sandler Yasmeen Rahimi $36.00 $15.80   127.85%
12/20/2022 Wedbush Andreas Argyrides $30.00 $18.05   66.2%

Verona Pharma plc FAQ's

Verona Pharma plc has been rated by research analysts at H.C. Wainwright, Wolfe Research, Piper Sandler, Cantor Fitzgerald, Roth Capital, Wells Fargo in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.